Desktop Analyzer Performs Chemical, Turbidimetric Tests, and Immunoassays

A desktop analyzer uses innovative technology to allow simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample.

The fully automated, random access analyzer is ideal for medium-sized and small laboratories, and it will provide diagnostic services to hospitals, clinics, and large medical practice facilities.


The analyzer, which is called DRG:Hybrid-XL, is also ideal for high work-load labs performing routine and niche diagnostic parameters on large automatic equipment. Up to 40 tests of different types or 40 times the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of prepackaged tests to serve different specialties, such as gynecology, oncology, prenatal supervision, cardiac markers, infectious diseases, and other common diseases.

DRG (Mountainside, NJ, USA) plans to showcase the new analyzer DRG:Hybrid-XL at MEDICA 2010, which will take place for four days from November 17, 2010 in Düsseldorf, Germany. It will be available for use in summer 2011.

Cyril E. Geacintov Ph.D., founder, CEO, and president of DRG, said, "The DRG:Hybrid-XL will allow laboratories to conduct specific testing on-site,” he says. "This will provide for faster and more accurate test results with greater convenience.”

Related Links:
DRG International Inc.